Subject Database
Clinilabs Drug Development Corporation provides access to the world’s largest population of racially diverse clinical trial participants. We recruit healthy volunteers, patients, and specialty groups from a population of more than 19 million people in the New York metropolitan area. Our on-site call center employs highly-experienced, multilingual associates who pre-screen study candidates using the latest technology in order to ensure that our proprietary database is the most robust in the industry. We currently have more than 43,000 study candidates in our database. Click here to determine if our database includes the subject population that you are seeking.
Clinilabs promotes gender and racial diversity in clinical trials, which we conduct to develop new therapies for the CNS disorders listed below.
Normal Healthy Subjects
Psychiatric Disorders
Neurological Disorders
Sleep Disorders
Endocrine and Metabolic Disorders
Infectious disease
Dermatologic disorders
Pulmonary Disease
Men’s and Women’s Health
Rare Disorders
I am not accustomed to saying anything with certainty after only one or two observations.
Remember the Three Princes of Serendip who went out looking for treasure? They didn’t find what they were looking for, but they kept finding things just as valuable. That’s serendipity, and our business [drugs] is full of it.
The reward for work well done is the opportunity to do more.
The greatest joy in life is to accomplish. It is the getting, not the having. It is the giving, not the keeping.
Advances in drug development have led to greater improvement in the quality of human life than advances in all other fields combined.
The cures we want aren’t going to fall from the sky. We have to get ladders and climb up and get them.
One never notices what has been done; one can only see what remains to be done.
The best way to predict the future is to invent it.
All truths are easy to understand once they are discovered; the point is to discover them.
I trust I may be enabled in the treatment of patients always to act with a single eye to their good.
I must say, I spend a lot of my time these days trying to persuade people that controlled trials are the only way to get information that’s reliable about drugs.
Drugs don’t work in patients who don’t take them.
One sometimes finds what one is not looking for.
It is easy to get a thousand prescriptions, but hard to get one single remedy.
Let me tell you the secret that has led me to my goal. My strength lies solely in my tenacity.
There is so much more to be done; the patients are waiting.
If you think compliance is expensive, try non-compliance.
I have no ideology. My ideology is health.
Good information is the best medicine.
Without drugs, physicians would struggle to find relevance, and patients would suffer without hope.
The pace of discovery is going unbelievably fast.